Literature DB >> 4101972

Antigen-specific cells in mouse bone marrow. I. Lasting effects of priming on immunocyte production by transferred marrow.

H C Miller, G Cudkowicz.   

Abstract

Graded numbers of marrow cells and 5 x 10(7) thymocytes were mixed in vitro and transplanted into X-irradiated (C3H x C57BL/10)F(1) mice. Upon injection of sheep or chicken erythrocytes, splenic plaque-forming cells secreting IgM (direct PFC) or IgG (indirect PFC) hemolytic antibody were enumerated at the time of peak responses. Anti-sheep and anti-chicken primary PFC responses elicited by nonimmune marrow cells differed sharply from each other under the conditions of limiting dilution assays. The frequencies of anti-chicken responses in recipients of different numbers of marrow cells conformed to the predictions of the Poisson model, while the frequencies of anti-sheep responses did not. Hence, the function of certain marrow-derived cells was expressed differentially during the two immune responses, to exclude that the same precursor units generated anti-sheep or anti-chicken PFC. The former precursor cells or units were functionally more heterogeneous than the latter. Immunization of marrow donors against sheep erythrocytes did not alter the population of cells engaged in anti-chicken responses, since limiting dilution assays with immune and nonimmune marrow cells gave identical results. However, anti-sheep immunization altered specifically the cell population engaged in anti-sheep responses, in two ways: (a) potentially immunocompetent marrow cells underwent antigen-dependent differentiation or maturation, to become functionally homogeneous. Consequently, the frequencies of PFC responses in limiting dilution assays conformed to the Poisson model; the changes occurred independently in class-restricted precursors of direct and indirect PFC. (b) marrow cells capable of inhibiting precursors of direct anti-sheep PFC arose in primed mice. The inhibition, which was specific, could have been effected directly by marrow cells or by a diffusable product such as IgG antibody. Results indicated that potentially immunocompetent cells of mouse marrow with distinct functions were antigen specific and antigen sensitive.

Entities:  

Mesh:

Substances:

Year:  1970        PMID: 4101972      PMCID: PMC2180502          DOI: 10.1084/jem.132.6.1122

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  26 in total

1.  Assignment of direct and facilitated hemolytic plaques in mice to specific immunoglobulin classes.

Authors:  P H Plotz; N Talal; R Asofsky
Journal:  J Immunol       Date:  1968-04       Impact factor: 5.422

2.  Immunological activity of thymus and thoracic-duct lymphocytes.

Authors:  G F Mitchell; J F Miller
Journal:  Proc Natl Acad Sci U S A       Date:  1968-01       Impact factor: 11.205

3.  Inactivation of thymus cells after multiple injections of antigen.

Authors:  R K Gershon; V Wallis; A J Davies; E Leuchars
Journal:  Nature       Date:  1968-04-27       Impact factor: 49.962

4.  Immunocompetence of transferred thymus-marrow cell combinations.

Authors:  H N Claman; E A Chaperon; R F Triplett
Journal:  J Immunol       Date:  1966-12       Impact factor: 5.422

5.  Antibody production studied by means of the LHG assay. I. The splenic response of CBA mice to sheep erythrocytes.

Authors:  H H Wortis; R B Taylor; D W Dresser
Journal:  Immunology       Date:  1966-12       Impact factor: 7.397

6.  Competition of 19S and 7S antigen receptors in the regulation of the primary immune response.

Authors:  C Henry; N K Jerne
Journal:  J Exp Med       Date:  1968-07-01       Impact factor: 14.307

7.  Cell to cell interaction in the immune response. II. The source of hemolysin-forming cells in irradiated mice given bone marrow and thymus or thoracic duct lymphocytes.

Authors:  G F Mitchell; J F Miller
Journal:  J Exp Med       Date:  1968-10-01       Impact factor: 14.307

8.  Cell to cell interaction in the immune response. 3. Chromosomal marker analysis of single antibody-forming cells in reconstituted, irradiated, or thymectomized mice.

Authors:  G J Nossal; A Cunningham; G F Mitchell; J F Miller
Journal:  J Exp Med       Date:  1968-10-01       Impact factor: 14.307

9.  Cellular differentiation of the immune system of mice. I. Separate splenic antigen-sensitive units for different types of anti-sheep antibody-forming cells.

Authors:  G M Shearer; G Cudkowicz; M S Connell; R L Priore
Journal:  J Exp Med       Date:  1968-09-01       Impact factor: 14.307

10.  Immunization of dissociated spleen cell cultures from normal mice.

Authors:  R I Mishell; R W Dutton
Journal:  J Exp Med       Date:  1967-09-01       Impact factor: 14.307

View more
  7 in total

1.  Defects in the immune system of mice infected with lymphocytic choriomeningitis virus.

Authors:  K Bro-Jorgensen; M Volkert
Journal:  Infect Immun       Date:  1974-04       Impact factor: 3.441

2.  The development of antigen-binding lymphocytes in foetal tissues.

Authors:  J M Dwyer; I R Mackay
Journal:  Immunology       Date:  1972-12       Impact factor: 7.397

3.  Thymus-independence of slowly metabolized immunogens.

Authors:  M Sela; E Mozes; G M Shearer
Journal:  Proc Natl Acad Sci U S A       Date:  1972-09       Impact factor: 11.205

4.  Graft-versus-host reactions in mice. IV. Thymus cell suppression of antibody formation.

Authors:  M Bennett; M Sturgeon; J P Engler
Journal:  Am J Pathol       Date:  1973-04       Impact factor: 4.307

5.  Immunologic memory cells of bone marrow origin. Increased burst size of specific immunocyte precursors.

Authors:  H C Miller; G Cudkowicz
Journal:  J Exp Med       Date:  1972-05-01       Impact factor: 14.307

6.  Antigen-specific cells in mouse bone marrow. II. Fluctuation of the number and potential of immunocyte precursors after immunization.

Authors:  H C Miller; G Cudkowicz
Journal:  J Exp Med       Date:  1971-05-01       Impact factor: 14.307

7.  Selective DNA synthesis by cells specifically localizing in response to xenogeneic erythrocytes.

Authors:  D R Thursh; E E Emeson
Journal:  J Exp Med       Date:  1973-09-01       Impact factor: 14.307

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.